Advocacy Wealth Management Services’s Puma Biotechnology PBYI Stock Holding History

Advocacy Wealth Management Services’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-200	Closed	-$4K	–	163
2018 Q4	$4K	Hold	200	–	–	﹤0.01%	142
2018 Q3	$9K	Hold	200	–	–	0.01%	136
2018 Q2	$12K	Hold	200	–	–	0.01%	119
2018 Q1	$14K	Hold	200	–	–	0.01%	113
2017 Q4	$20K	Hold	200	–	–	0.01%	109
2017 Q3	$24K	Hold	200	–	–	0.01%	119
2017 Q2	$17K	Hold	200	–	–	0.01%	150
2017 Q1	$7K	Hold	200	–	–	﹤0.01%	240
2016 Q4	$6K	Hold	200	–	–	﹤0.01%	242
2016 Q3	$13K	Buy	+200	New	+$10.1K	0.01%	247

Other funds holding PBYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Advocacy Wealth Management Services's PBYI Position: Q1 2019 in Review

Advocacy Wealth Management Services sold out of Puma Biotechnology (PBYI) in Q1 2019, closing a stake of 200 shares — an estimated $4K sold.

Advocacy Wealth Management Services first reported a position in PBYI in Q3 2016 and held it in 10 quarters. The position peaked at $24K in Q3 2017. 158 funds tracked by Wall St. Rank hold PBYI as of Q1 2019.

Advocacy Wealth Management Services reported no remaining Puma Biotechnology position as of Q1 2019 after selling out during the quarter.
Advocacy Wealth Management Services sold 200 Puma Biotechnology shares in Q1 2019, an estimated $4K.
Advocacy Wealth Management Services first reported a position in Puma Biotechnology in Q3 2016 and held it in 10 quarters.
Advocacy Wealth Management Services's Puma Biotechnology position peaked at $24K in Q3 2017.
158 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2019.

Based on Advocacy Wealth Management Services's 13F filing for Q1 2019, filed 2 Apr 2019.